HMSCs by inducing PI-3K-dependent chemotaxis. Taken together, these data suggest that HIMF plays an important role in the recruitment of BMD cells to the remodeling pulmonary vasculature. Acknowledgments The authors thank Ms. Claire Levine for critical review and assistance with the manuscript preparation. References 1. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19: 4046–4055. 2. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, et al. (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98: 502–506. 3. Teng X, Li D, Champion HC, Johns RA (2003) FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res 92: 1065–1067. 4. Angelini DJ, Su Q, Yamaji-Kegan K, Fan C, Skinner JT, et al. (2009) Hypoxia- Induced Mitogenic Factor (HIMF) Is Involved in the Pulmonary Vascular Remodeling Associated with Chronic Hypoxia and Inflammatory Asthma. American Thoracic Society International Conference. 5. Su Q, Zhou Y, Johns RA (2007) Bruton’s tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis. FASEB J 21: 1376–1382. 6. Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC, Johns RA (2006) Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 291: L1159–L1168. 7. Angelini DJ, Su Q, Yamaji-Kegan K, Fan C, Skinner JT, et al. (2009) Hypoxia- induced mitogenic factor (HIMF/FIZZ1/RELMa) induces the vascular and hemodynamic changes of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 296: L582–L593. 8. Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA, et al. (2004) FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 164: 1315–1326. 9. Chung MJ, Liu T, Ullenbruch M, Phan SH (2007) Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts. J Pathol 212: 180–187. 10. Tong Q, Zheng L, Lin L, Li B, Wang D, et al. (2006) Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI- 3K/Akt-NF-kappaB signaling pathway. Am J Respir Cell Mol Biol 35: 444–456. 11. Davie NJ, Crossno JT, Jr., Frid MG, Hofmeister SE, Reeves JT, et al. (2004) Hypoxia-induced pulmonary artery adventitial remodeling and neovasculariza- tion: contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 286: L668–L678. 12. Spees JL, Whitney MJ, Sullivan DE, Lasky JA, Laboy M, et al. (2008) Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 22: 1226–1236. HIMF and Stem Cells Author Contributions Conceived and designed the experiments: DJA QS IAK RAJ. Performed the experiments: DJA QS IAK CF JTS KYK MC. Analyzed the data: DJA QS IAK CF KYK SJS RAJ. Contributed reagents/materials/analysis tools: SJS RAJ. Wrote the paper: DJA QS IAK RAJ. 13. Biankin SA, Collector MI, Biankin AV, Brown LJ, Kleeberger W, et al. (2007) A histological survey of green fluorescent protein expression in ‘green’ mice: implications for stem cell research. Pathology 39: 247–251. 14. Lanzkron SM, Collector MI, Sharkis SJ (1999) Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. Blood 93: 1916–1921. 15. Girgis RE, Li D, Zhan X, Garcia JG, Tuder RM, et al. (2003) Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol 285: H938–H945. 16. Girgis RE, Mozammel S, Champion HC, Li D, Peng X, et al. (2007) Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol 292: L1105–L1110. 17. Quinlan TR, Li D, Laubach VE, Shesely EG, Zhou N, et al. (2000) eNOS- deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 279: L641–L650. 18. Xue C, Johns RA (1996) Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. Hypertension 28: 743–753. 19. Aliotta JM, Keaney P, Passero M, Dooner MS, Pimentel J, et al. (2006) Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol 34: 230–241. 20. Herzog EL, Chai L, Krause DS (2003) Plasticity of marrow-derived stem cells. Blood 102: 3483–3493. 21. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M (2001) Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7: 382–383. 22. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, et al. (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403–409. 23. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, et al. (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100: 4754–4759. 24. Hayashida K, Fujita J, Miyake Y, Kawada H, Ando K, et al. (2005) Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia- induced pulmonary hypertension. Chest 127: 1793–1798. 25. Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, et al. (2008) Adult stem cells and their trans-differentiation potential–perspectives and therapeutic applications. J Mol Med 86: 1301–1314. 26. Lindvall J, Islam TC (2002) Interaction of Btk and Akt in B cell signaling. Biochem Biophys Res Commun 293: 1319–1326. PLoS ONE | www.plosone.org 10 June 2010 | Volume 5 | Issue 6 | e11251